Baiyang Pharmaceuticals: Plans to invest 27 million yuan in Sihui Genetics, holding a 10% stake

Baiyang Pharmaceutical Announcement: The company plans to sign an “Investment Agreement” with related parties such as Sihe Gene and Mentougou Baiyang Fund, investing 27 million yuan in Sihe Gene in cash, holding a 10% stake after the investment. This transaction constitutes a related-party transaction involving joint investment with professional investment institutions and has been approved by the board of directors. Sihe Gene is a biotechnology company focused on the research and development of next-generation single-stranded oligonucleotide (ASO) drugs. The company’s investment aims to expand its presence in the field of small nucleic acid drugs.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin